CARO CENTER — History
CCN 234025 | 3-year financial timeline | COVID resilience: 78/100
🛡️ Public data only — no PHI permitted on this instance.
$8M
Latest Revenue (FY2022)
+28.4%
Revenue CAGR (3yr)
-100.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $5M | $10M | $8M | -18.7% | +28.4% |
| Operating Expenses | $57M | $55M | $59M | +7.7% | +1.6% |
| Operating Margin | -100.0% | -100.0% | -100.0% | +0.0% | +0.0% |
| Net Income | $-52M | $-45M | $-51M | -13.6% | +0.0% |
| Licensed Beds | 154 | 154 | 182 | +18.2% | +8.7% |
| Total Patient Days | 35,809 | 36,725 | 36,000 | -2.0% | +0.3% |
| Medicare Day % | 2% | 5% | 6% | +5.4% | +94.5% |
| Medicaid Day % | 12% | 10% | 9% | -5.6% | -12.9% |
COVID Impact & Recovery
Resilience Score: 78/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +64.9% ($5M → $8M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+28.4%
This Hospital
+7.6%
State Avg
Latest Margin
-100.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $10M | -100.0% |
| FY2024 (proj) | $11M | -100.0% |
| FY2025 (proj) | $13M | -100.0% |